Skip to main navigation Skip to search Skip to main content

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.

  • The Second Affiliated Hospital of Xi'an Jiaotong University
  • First Affiliated Hospital of Zhengzhou University

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
Pages (from-to)931
Number of pages1
JournalNew England Journal of Medicine
Volume392
Issue number9
DOIs
StatePublished - 27 Feb 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this